ClinicalTrials.gg
CompletedNCT00979433Updated Feb 26, 2013

Bubble Continuous Positive Airway Pressure (CPAP) With Conventional CPAP for Extubation in Preterm Infants

An interventional study of Bubble CPAP and Conventional CPAP in Extubation Failure, sponsored by All India Institute of Medical Sciences. Completed at 1 site in India. Open to participants aged Up to 7 Days. Per ClinicalTrials.gov, last updated 2013-02-26.

Sponsored by All India Institute of Medical Sciences · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
32
Allocation
Randomized
Ages
Up to 7 Days
Sex
All
01

Study summary

The objective of this study is to evaluate whether CPAP delivered by bubble CPAP resulted in a greater proportion of infants being successfully extubated when compared with management with ventilator derived CPAP.

Read the detailed description

There have been no published randomized trials comparing extubation failure rates of Bubble CPAP with conventional ventilator derived CPAP. Infants of gestation \<32 weeks and of birth weight less than 1500 grams considered by the treating team to be ready for the initial extubation within first week of life were screened for enrolment. All eligible neonates were randomly allocated to bubble CPAP or conventional CPAP.The purpose of this study is to compare whether infants on Bubble CPAP had more chances of successful extubation as compared to infants put on Conventional CPAP.

02

Conditions studied

  • Extubation Failure

Keywords

  • Extubation failure
  • Continuous positive airway pressure
  • Bubble CPAP
03

In context

Lead sponsor

All India Institute of Medical Sciences is the lead sponsor of 27 studies on the registry; 18 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 7 Days
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Gestation less than 32 weeks
  • Birth weight less than 1500 g
  • Age less than seven days
  • First extubation attempt.

Exclusion criteria

Exclusion Criteria:

  • A neonate having any of the following will be excluded from the study-
  • Severe birth asphyxia defined as need for chest compression for more than 30 seconds
  • Suspected congenital neuromuscular disorder
  • Major congenital malformation
  • Grade 3/4 interventricular haemorrhage
  • Hydrops.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
32 participants (actual)

Study arms

  • Experimental
    Bubble CPAP

    All neonates randomised to bubble CPAP will be put on Bubble CPAP following initial extubation in first week of life.

    Device: Bubble CPAP

  • Other
    Conventional CPAP

    All neonates randomly allocated to conventional/ventilator derived CPAP.

    Device: Conventional CPAP

Interventions

  • DeviceBubble CPAP

    Bubble CPAP will be delivered using Fischer \& Paykel CPAP system with a starting flow of 6 liters/minute. CPAP will be initially started at a pressure of 5 - 6 cm H2O and fraction of inspired oxygen (FiO2) of 0.4 - 0.5. which will be adjusted to maintain oxygen saturation (SpO2) between 87 and 93%.

    Also known as: Fisher & Paykel Bubble CPAP System

  • DeviceConventional CPAP

    Conventional CPAP will be delivered using Argyle CPAP (Sherwood Medical Company, Mexico) short nasal prongs with warm, humidified gas used (34-37°C) through a thermo-statically controlled humidifier, flow @ 4-8 L/min from either SLE 2000 pressure-controlled continuous flow ventilator (Specialized Laboratory Equipment, UK) or Baby log 8000 volume guarantee ventilator.

06

What researchers measure

Primary outcomes

  1. Extubation failure - defined as need for reintubation and mechanical ventilation for any reason within 72 hours of initial extubation

    Time frame: Till 72 hours after extubation

Secondary outcomes

  1. Time to extubation failure in hours.

    Time frame: till extubation failure within first 72 hours after extubation

07

Study locations

1 site
  • All India Institute of Medical Sciences
    New Delhi, National Capital Territory of Delhi, India
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 26, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00979433
Lead sponsor
All India Institute of Medical Sciences
Responsible party
Ramesh K Agarwal (Associate Professor, All India Institute of Medical Sciences) — Principal investigator
First posted
Sep 18, 2009
Start date
Sep 2007
Primary completion
Nov 2009
Completion
Nov 2009
Last update
Feb 26, 2013

Study contacts

Vinod K Paul, MD PhD
study chair · Department of Pediatrics, All India Institute of Medical Sciences, New Delhi
Sucheta Yadav, MBBS
principal investigator · Department of Pediatrics, All India Institute of Medical Sciences, New Delhi
Mari J Sankar, MD, DM
study chair · Department of Pediatrics, All India Institute of Medical Sciences, New Delhi
Ramesh Agarwal, MD, DM
study chair · Department of Pediatrics, All India Institute of Medical Sciences, New Delhi

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion